CVS Caremark posts higher profit, helped by flu season, generics
NEW YORK May 1 (Reuters) - CVS Caremark Corp posted higher quarterly profit on Wednesday, as a more severe cold and flu season boosted sales and more new generic drugs hit the market.
CVS said net income rose to $956 million, or 77 cents per share, in the quarter ended March 31, from $776 million, or 59 cents, a year earlier.
Revenue in the pharmacy benefits management (PBM) unit, which administers drug benefits for employers and health plans and runs a large mail order pharmacy, rose 0.1 percent to $18.31 billion. Revenue in the retail division rose 0.2 percent to $10.05 billion.
Overall revenue slipped 0.1 percent to $30.76 billion in the quarter, but was above the $30.36 billion that Wall Street expected, according to Thomson Reuters I/B/E/S.
- Israel pummels Gaza; Kerry steps up diplomatic push |
- With sales sputtering, Apple's iPad looks to IBM alliance
- Ukraine war crimes trials a step closer after Red Cross assessment
- Rebels likely downed Malaysian jet 'by mistake': U.S. officials
- Five held in China food scandal probe, including head of Shanghai Husi Food